Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Change in Accured Expenses (2019 - 2026)

Praxis Precision Medicines (PRAX) posted Change in Accured Expenses of $6.9 million for Q2 2026, up 139.91% on a QoQ basis from -$17.4 million in Q1 2026, and up 99.74% year-over-year from $3.5 million in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Praxis Precision Medicines has reported Change in Accured Expenses for 8 years, with the latest figure at $6.9 million in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 99.74% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 36.17% decrease from a year earlier, with the FY2025 full-year figure at $11.2 million, down 30.48% from the prior year.
  • Change in Accured Expenses was $6.9 million for Q2 2026 at Praxis Precision Medicines, up from -$17.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $14.4 million in Q4 2025, with the low at -$17.4 million in Q1 2026.
  • Average Change in Accured Expenses over 5 years is -$116555.6, with a median of $976000.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 1491.64% in 2022, then soared 2067.11% in 2024.
  • Over 5 years, Change in Accured Expenses stood at -$2.0 million in 2022, then soared by 118.39% to $374000.0 in 2023, then jumped by 2067.11% to $8.1 million in 2024, then surged by 78.01% to $14.4 million in 2025, then slumped by 51.91% to $6.9 million in 2026.
  • The last three Change in Accured Expenses figures came in at $6.9 million (Q2 2026), -$17.4 million (Q1 2026), and $14.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 852.00 Mn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 338.00 Mn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 222.50 Mn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 492.70 Mn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 11.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 61.62 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -49.70 Mn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -13.91 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - 6.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.94 Mn
Mar 31, 2026 -17.39 Mn
Dec 31, 2025 14.43 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 3.47 Mn
Mar 31, 2025 -8.28 Mn
Dec 31, 2024 8.11 Mn
Sep 30, 2024 5.41 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 -608,000.00
Dec 31, 2023 374,000.00
Sep 30, 2023 -6.34 Mn
Jun 30, 2023 3.97 Mn
Mar 31, 2023 -6.50 Mn
Dec 31, 2022 -2.03 Mn
Sep 30, 2022 -7.88 Mn
Jun 30, 2022 -5.16 Mn
Mar 31, 2022 4.62 Mn
Dec 31, 2021 9.97 Mn
Sep 30, 2021 8.59 Mn
API Access

Praxis Precision Medicines Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PRAX&period=max&api_key=YOUR_API_KEY